A detailed history of Orbimed Advisors LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 708,400 shares of DYN stock, worth $16.9 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
708,400
Previous 708,400 -0.0%
Holding current value
$16.9 Million
Previous $25 Million 1.78%
% of portfolio
0.6%
Previous 0.6%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.06 - $29.18 $9.25 Million - $20.7 Million
708,400 New
708,400 $20.1 Million
Q3 2022

Nov 14, 2022

BUY
$7.2 - $15.17 $1.59 Million - $3.34 Million
220,400 New
220,400 $2.8 Million
Q3 2021

Nov 15, 2021

SELL
$15.6 - $21.46 $5.46 Million - $7.51 Million
-350,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$20.0 - $23.9 $7 Million - $8.36 Million
350,000 New
350,000 $7.07 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.